Abstract
Objectives: To describe the clinicopathologic findings of seven patients with CD5-positive nodal marginal zone lymphoma (NMZL). Methods: We searched cases of NMZL over a 10-year interval and identified seven cases of CD5-positive NMZL. The clinical, histologic, and immunophenotypic findings of this group were reviewed, and the frequency of dissemination in this group was compared with that of 66 patients with CD5-negative NMZL. Results: Other than CD5 expression, the histologic and immunophenotypic findings were typical of NMZL. Six (86%) of seven patients had lymphadenopathy above and below the diaphragm, and all six patients assessed had bone marrow involvement. In the CD5-negative group, 28 (42%) patients had lymphadenopathy above and below the diaphragm, and 36 (55%) had bone marrow involvement (P = .045 and P = .037, respectively). Six of seven patients were alive at last follow-up, with a median follow-up of 32 months (3-154 months). Conclusions: CD5 expression in NMZL correlates with a higher frequency of dissemination, but patients have an indolent clinical course and excellent overall survival. © American Society for Clinical Pathology.
Author supplied keywords
Cite
CITATION STYLE
Jaso, J. M., Yin, C. C., Wang, S. A., Miranda, R. N., Jabcuga, C. E., Chen, L., & Medeiros, L. J. (2013). Clinicopathologic features of CD5-positive nodal marginal zone lymphoma. American Journal of Clinical Pathology, 140(5), 693–700. https://doi.org/10.1309/AJCPEMVXES72DUIF
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.